Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2013 May 01;1692:384-99. doi: 10.1111/bph.12153.
Show Gene links
Show Anatomy links
Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.
Varagic Z
,
Ramerstorfer J
,
Huang S
,
Rallapalli S
,
Sarto-Jackson I
,
Cook J
,
Sieghart W
,
Ernst M
.
???displayArticle.abstract??? GABAA receptors are the major inhibitory neurotransmitter receptors in the mammalian brain and the target of many clinically important drugs interacting with different binding sites. Recently, we demonstrated that CGS 9895 (2-(4-methoxyphenyl)-2H-pyrazolo[4,3-c]quinolin-3(5H)-one) elicits a strong and subtype-dependent enhancement of GABA-induced currents via a novel drug-binding site at extracellular αx+βy- (x = 1-6, y = 1-3) interfaces. Here, we investigated 16 structural analogues of CGS 9895 for their ability to modulate GABA-induced currents of various GABAA receptor subtypes. Recombinant GABAA receptor subtypes were expressed in Xenopus laevis oocytes and investigated by the two-electrode voltage clamp method. Most of the compounds investigated were able to modulate GABA-induced currents of αβ and αβγ receptors to a comparable extent, suggesting that the effect of these drugs is not dependent on the benzodiazepine site of GABAA receptors. Steric hindrance experiments demonstrated that these compounds exert their action predominantly via the αx+βy- (x = 1-6, y = 1-3) interfaces. Whereas some compounds are unselectively modulating a broad range of receptor subtypes, other compounds feature remarkable functional selectivity for the α6β3γ2 receptor, or behave as null modulators at some receptor subtypes investigated. Pyrazoloquinolinones and pyrazolopyridinones represent the first prototypes of drugs exerting benzodiazepine-like modulatory effects via the α+β- interface of GABAA receptors. The discovery of modulators with functional subtype selectivity at this class of binding sites provides a highly useful tool for the investigation of α6β2/3γ2 receptor function, and may lead to novel therapeutic principles.
Brown,
In vivo determination of efficacy of pyrazoloquinolinones at the benzodiazepine receptor.
1984, Pubmed
Brown,
In vivo determination of efficacy of pyrazoloquinolinones at the benzodiazepine receptor.
1984,
Pubmed
Ebert,
Extensive heterogeneity of recombinant gamma-aminobutyric acidA receptors expressed in alpha 4 beta 3 gamma 2-transfected human embryonic kidney 293 cells.
1996,
Pubmed
Gao,
Distributed synergistic plasticity and cerebellar learning.
2012,
Pubmed
Gutiérrez,
Immunocytochemical localization of the alpha 6 subunit of the gamma-aminobutyric acidA receptor in the rat nervous system.
1996,
Pubmed
Hadley,
Rat alpha6beta2delta GABAA receptors exhibit two distinct and separable agonist affinities.
2007,
Pubmed
,
Xenbase
He,
Pharmacophore/receptor models for GABA(A)/BzR alpha2beta3gamma2, alpha3beta3gamma2 and alpha4beta3gamma2 recombinant subtypes. Included volume analysis and comparison to alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2 subtypes.
2000,
Pubmed
Horton,
Gene splicing by overlap extension.
1993,
Pubmed
Li,
Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1,5a]- [1,4]benzodiazepine analogue, the first bivalent alpha5 subtype selective BzR/GABA(A) antagonist.
2003,
Pubmed
,
Xenbase
Loo,
Benzodiazepine receptor modulation of [35S]TBPS binding to the chloride channel. Noncompetitive inhibition of classical benzodiazepines and competitive inhibition of the partial agonist, CGS 9895, by CGS 8216.
1987,
Pubmed
Maison,
Functional role of GABAergic innervation of the cochlea: phenotypic analysis of mice lacking GABA(A) receptor subunits alpha 1, alpha 2, alpha 5, alpha 6, beta 2, beta 3, or delta.
2006,
Pubmed
Ogris,
Affinity of various benzodiazepine site ligands in mice with a point mutation in the GABA(A) receptor gamma2 subunit.
2004,
Pubmed
Olsen,
International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update.
2008,
Pubmed
Pirker,
GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain.
2000,
Pubmed
Ramerstorfer,
The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes.
2010,
Pubmed
Ramerstorfer,
The GABAA receptor alpha+beta- interface: a novel target for subtype selective drugs.
2011,
Pubmed
,
Xenbase
Richter,
Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands.
2012,
Pubmed
Rudolph,
Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.
1999,
Pubmed
Sieghart,
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
1995,
Pubmed
Sieghart,
A novel GABA(A) receptor pharmacology: drugs interacting with the α(+) β(-) interface.
2012,
Pubmed
Sigel,
Mapping of the benzodiazepine recognition site on GABA(A) receptors.
2002,
Pubmed
Sigel,
The effect of subunit composition of rat brain GABAA receptors on channel function.
1990,
Pubmed
,
Xenbase
Smith,
Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux.
2001,
Pubmed
Thompson,
The role of the cerebellum in classical conditioning of discrete behavioral responses.
2009,
Pubmed
Tretter,
Stoichiometry and assembly of a recombinant GABAA receptor subtype.
1997,
Pubmed
Varagic,
Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interface.
2013,
Pubmed
,
Xenbase
Williams,
CGS 20625, a novel pyrazolopyridine anxiolytic.
1989,
Pubmed
Wisden,
The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon.
1992,
Pubmed
